長和(00001.HK):擬邀請來自中國內地的主要策略投資者加入成爲財團的重要成員
格隆匯7月28日丨長和(00001.HK)發佈公告,公司確認,於2025年3月4日公司發佈的公告中所述,集團與一財團的間的獨家磋商期已屆滿。
儘管該期限已屆滿,集團仍在與財團成員進行討論,擬邀請來自中國內地的主要策略投資者加入成爲財團的重要成員。爲使交易能夠獲得所有相關監管機構和部門的批準,財團的成員以及交易架構將需要進行變更(“新安排”)。集團打算預留充分的時間進行相關討論,以達成新安排。
公司已多次聲明,在未獲得所有相關監管機構和部門批準前,公司將不會進行任何交易(請參考公司早前的通訊)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.